FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319294226> ?p ?o ?g. }

• W4319294226 endingPage "538" @default.
• W4319294226 startingPage "535" @default.
• W4319294226 abstract "Iron has been around since shortly after the Big Bang and has been present on planet Earth from the start, forming much of its core and crust, where it has served as a prima essentia of life since before the Great Oxidation Event ∼2.4 billion years ago (Bailey & Poole, 2022; Sheftel et al., 2012). Iron is involved in numerous physiological mechanisms, including hypoxic vasoconstriction, a phylogenetically ancient vascular reflex conserved across all vertebrates, thus present in fish gills and amphibian skin, in addition to the lungs of most reptiles, birds and mammals (Russell et al., 2008). In Mammalia, it manifests as hypoxic pulmonary vasoconstriction (HPV), which ensures the preservation of fetal oxygenation during placental gestation by reducing blood flow through the non-ventilated lungs. HPV also plays important roles postnatally in relationship to several extreme physiological and clinical phenomena, helping to restore the matching of pulmonary perfusion to ventilation when hypoxic regions in the lung develop. There is a renewed interest in the mechanisms and (mal)adaptability of HPV in humans, highlighted in recent publications focused on static apnoea and high-altitude acclimatization (Jernigan et al., 2021; Kelly et al., 2022; Subedi et al., 2022). These studies have confirmed the modulatory significance of iron on HPV, providing clues to the limits of physiological adaptation to terrestrial extremes that have translational relevance for mechanisms of disease. As outlined below, impaired HPV and changes in iron homeostasis are both prominent features in chronic obstructive pulmonary disease (COPD), and the recent studies thus shed light on putative mechanisms of impaired pulmonary gas exchange in this condition. The site of HPV is pulmonary vascular smooth muscle (PVSMCs), notably in arterial vessels, and encompasses three interconnected steps: (1) physiological sensing of reduced alveolar (not blood) oxygen tension; (2) initial PVSMC contraction; and (3) subsequent modulation of PVSMC contraction (Smith & Schumacker, 2019). Together, these steps lead to a characteristic biphasic response, with an initial increase in pulmonary vascular resistance that peaks within 5 min and a more gradual increase that reaches a sustained maximum at 30–60 min (Figure 1a). Phase 1 consists of steps 1 and 2 and depends on the formation of free radicals and associated reactive oxygen species (ROS) that trigger PVSMC contraction through local intracellular effects and by a superoxide anion-mediated reduction in the vascular bioavailability of NO (Figure 1b). Step 3 occurs during phase 2 and largely depends on changes in the gene expression of hypoxia-inducible factors (HIFs), with a subsequent release of vasoactive substances within the pulmonary vasculature (Figure 1c). Of note, all three steps involve altered redox status and are thus susceptible to changes in iron homeostasis, but an apparent paradox is at play here. Thus, although both hypoxia per se and iron loading increase ‘free catalytic’ (i.e. ferrous) iron (Fe2+) (Bailey et al., 2022), which one would expect to enhance PVSMC contraction (Figure 1b), free catalytic iron also functions to reduce PVSMC contraction by increased degradation of HIF through effects on prolyl hydroxylase domain enzymes (Figure 1c). In two recent studies, one from the UBC-Nepal Expedition, conducted at The Pyramid International Laboratory at 5050 m, and the other the GLOBAL REACH 2018 study, conducted at 4300 m in Cerro de Pasco, Peru, a 220 mg i.v. iron(III)-hydroxide sucrose infusion blunted the HPV response to ascent in lowlanders, Sherpa and Andeans (Patrician et al., 2022; Willie et al., 2021). Although ascent caused a reduction in serum iron, transferrin and transferrin saturation (Willie et al., 2021), no measurements of free catalytic iron or other measures of redox status were made in the two studies, and it remains to be documented that iron loading by this approach causes an increase in free catalytic iron in the pulmonary vascular bed. However, when considering the aforementioned ‘push and pull’ of iron homeostasis on HPV, the results might be interpreted to reflect that rather than driving the final steady-state response, NO scavenging primarily functions hermetically to titrate the effects of HIF-dependent pathways on pulmonary vascular resistance, to fine-tune regional ventilation–perfusion matching (Figure 1d). In COPD, chronic hypoxaemia is an independent predictor of death and is notoriously difficult to manage (Martinez et al., 2006). It evolves owing to airway, alveolar and pulmonary vascular abnormalities, causing an uneven distribution of alveolar ventilation relative to perfusion. In this regard, HPV functions to match perfusion to the uneven ventilation, thus preventing or alleviating hypoxaemia according to studies based on the classical multiple inert gas elimination technique conducted in patients with stable COPD of various severities (Agusti et al., 1990; Barberà et al., 1996). The lungs of stable COPD patients with resting hypoxaemia are dominated by areas with low ventilation–perfusion ratios, indicating impaired HPV (Wagner et al., 1977). This is supported by in vitro studies on pulmonary vascular specimens obtained from lungs of patients with mild-to-moderate and severe COPD, undergoing either lung resection or lung transplantation, in which HPV has been reported to be weaker in hypoxaemic than in non-hypoxaemic COPD patients (Peinado et al., 2002, 2013). Furthermore, during COPD exacerbations, which are characterized by an acute and sustained worsening of symptoms, hypoxaemia is associated with greater perfusion of poorly ventilated areas (Barberà et al., 1997). These findings thus support the failure of HPV as a unifying mechanism of hypoxaemia, both in stable COPD and during acute exacerbations. The impact of iron-redox homeostasis on HPV remains to be investigated directly in COPD (Cloonan et al., 2017), but it is worth noting that despite both systemic anaemic and non-anaemic iron deficiency being common in COPD, the lung tissue of COPD patients consistently exhibits increases in iron content and iron-binding molecules (Silverberg et al., 2014). This is further exaggerated during acute exacerbations, probably driven by increased iron sequestration within the lung tissue and vasculature (Cloonan et al., 2017). Although no studies have yet reported free catalytic iron levels in blood or lung tissue, either in stable COPD or during acute exacerbations, we postulate that disrupted iron homeostasis is a likely catalyst that drives the shift from a non-hypoxaemic to a hypoxaemic phenotype in COPD. Collectively, the available studies at present indicate the importance of taking an integrated physiological approach, by combining findings and concepts from the extreme, the classical, the healthy and the ill, to determine precisely how iron and its ancient gaseous partner oxygen, both formed in dying stars billions of years ago, contribute to the impairment of HPV in COPD. Jacob Peter Hartmann: conception, first draft, figure and revisions. Damian M. Bailey: revisions and supervision. Ronan M. G. Berg: conception, first draft, revisions, figure and supervision. All authors approved the final version of the manuscript and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed. None declared. The Centre for Physical Activity Research (CFAS) is supported by TrygFonden (grants 101390 and 20045). J.P.H. is supported by Rigshospitalet Research Foundation and HelseFonden. D.M.B. is supported by a Royal Society Wolfson Research Fellowship (#WM170007)." @default.
• W4319294226 created "2023-02-07" @default.
• W4319294226 creator A5044523050 @default.
• W4319294226 creator A5059403151 @default.
• W4319294226 creator A5091280871 @default.
• W4319294226 date "2023-02-06" @default.
• W4319294226 modified "2023-10-13" @default.
• W4319294226 title "A song of iron and oxygen: Hypoxic pulmonary vasoconstriction and gas exchange in chronic obstructive pulmonary disease" @default.
• W4319294226 cites W1976313659 @default.
• W4319294226 cites W1998628577 @default.
• W4319294226 cites W2060389868 @default.
• W4319294226 cites W2110163221 @default.
• W4319294226 cites W2116950781 @default.
• W4319294226 cites W2121519429 @default.
• W4319294226 cites W2131626846 @default.
• W4319294226 cites W2133936382 @default.
• W4319294226 cites W2150700731 @default.
• W4319294226 cites W2160488228 @default.
• W4319294226 cites W2605628036 @default.
• W4319294226 cites W2894677876 @default.
• W4319294226 cites W3110650814 @default.
• W4319294226 cites W3196851776 @default.
• W4319294226 cites W3197422366 @default.
• W4319294226 cites W4223462033 @default.
• W4319294226 cites W4292596046 @default.
• W4319294226 cites W4294845112 @default.
• W4319294226 cites W4309511162 @default.
• W4319294226 doi "https://doi.org/10.1113/ep091078" @default.
• W4319294226 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36744659" @default.
• W4319294226 hasPublicationYear "2023" @default.
• W4319294226 type Work @default.
• W4319294226 citedByCount "1" @default.
• W4319294226 crossrefType "journal-article" @default.
• W4319294226 hasAuthorship W4319294226A5044523050 @default.
• W4319294226 hasAuthorship W4319294226A5059403151 @default.
• W4319294226 hasAuthorship W4319294226A5091280871 @default.
• W4319294226 hasBestOaLocation W43192942261 @default.
• W4319294226 hasConcept C126322002 @default.
• W4319294226 hasConcept C164705383 @default.
• W4319294226 hasConcept C178790620 @default.
• W4319294226 hasConcept C185592680 @default.
• W4319294226 hasConcept C2779134260 @default.
• W4319294226 hasConcept C2779961880 @default.
• W4319294226 hasConcept C29323129 @default.
• W4319294226 hasConcept C2992779976 @default.
• W4319294226 hasConcept C540031477 @default.
• W4319294226 hasConcept C71924100 @default.
• W4319294226 hasConcept C7836513 @default.
• W4319294226 hasConceptScore W4319294226C126322002 @default.
• W4319294226 hasConceptScore W4319294226C164705383 @default.
• W4319294226 hasConceptScore W4319294226C178790620 @default.
• W4319294226 hasConceptScore W4319294226C185592680 @default.
• W4319294226 hasConceptScore W4319294226C2779134260 @default.
• W4319294226 hasConceptScore W4319294226C2779961880 @default.
• W4319294226 hasConceptScore W4319294226C29323129 @default.
• W4319294226 hasConceptScore W4319294226C2992779976 @default.
• W4319294226 hasConceptScore W4319294226C540031477 @default.
• W4319294226 hasConceptScore W4319294226C71924100 @default.
• W4319294226 hasConceptScore W4319294226C7836513 @default.
• W4319294226 hasFunder F4320324424 @default.
• W4319294226 hasIssue "4" @default.
• W4319294226 hasLocation W43192942261 @default.
• W4319294226 hasLocation W43192942262 @default.
• W4319294226 hasOpenAccess W4319294226 @default.
• W4319294226 hasPrimaryLocation W43192942261 @default.
• W4319294226 hasRelatedWork W2000548402 @default.
• W4319294226 hasRelatedWork W2002601654 @default.
• W4319294226 hasRelatedWork W2021015175 @default.
• W4319294226 hasRelatedWork W2023528360 @default.
• W4319294226 hasRelatedWork W2036514051 @default.
• W4319294226 hasRelatedWork W2043487692 @default.
• W4319294226 hasRelatedWork W2095896860 @default.
• W4319294226 hasRelatedWork W2101022307 @default.
• W4319294226 hasRelatedWork W2394616360 @default.
• W4319294226 hasRelatedWork W3030558928 @default.
• W4319294226 hasVolume "108" @default.
• W4319294226 isParatext "false" @default.
• W4319294226 isRetracted "false" @default.
• W4319294226 workType "article" @default.